Amends the Nurse Practice Act. Provides that, in order to protect the public and ensure safe and adequate health care services, if the Department of Financial and Professional Regulation finds that any person licensed or authorized to practice under the Act was not properly credentialed pursuant to the standards required at the time of application, the Department may temporarily suspend the person's license or authorization to practice without prior hearing until the Department receives satisfactory evidence of the licensee's overall qualifications. Provides that the Department shall notify the licensee of the temporary suspension at the licensee's address of record or email address of record. Provides that the licensee may request that the Board review the validity of the license within 30 days after the service of the notice and shall submit written evidence in support of the licensee's qualifications with the request for review. Provides that the licensee may seek an extension of time to provide such evidence, during which the suspension shall remain in effect. Provides that the Board, at its next regularly scheduled meeting, shall review the request and any written evidence provided by the licensee and make a final recommendation regarding the licensee's qualifications to the Director of the Division of Professional Regulation of the Department. Provides that, based upon the Board's final recommendation, the Director of the Division of Professional Regulation may issue an order withdrawing the license due to the licensee's lack of qualifications or lift the suspension of the license by stipulating terms and conditions of practice. Provides that withdrawal of the license alone shall not constitute discipline or be a bar to licensure if the licensee makes a subsequent reapplication that meets the qualifications under the Act. Provides that disciplinary proceedings may also be initiated pursuant to the Board's recommendation or Department findings and shall be conducted in the same manner as other disciplinary proceedings under the Act. Sets forth rulemaking authority for the Department.
Senate Floor Amendment No. 1: Adds an immediate effective date.
House Floor Amendment No. 1: Replaces everything after the enacting clause. Creates the Prescription Drug Affordability Board Act. Establishes the Prescription Drug Affordability Board and the Prescription Drug Affordability Stakeholder Council. Sets forth provisions concerning membership and staff of the Board and the Council, conflicts of interest, powers and duties of the Board, operational plans for distribution and access to a drug with an upper payment limit, reporting requirements for the Board, and term expiration for the Board and the Council. Provides that the Board shall limit its review to the specified prescription drug products. Establishes further affordability review and upper payment limit implementation requirements. Provides that the Attorney General may enforce the Act. Permits a person aggrieved by a decision of the Board to request an appeal of the decision. Creates the Prescription Drug Affordability Board Fund. Provides that the Act is repealed 5 years after the Act's effective date. Amends the State Finance Act to make a conforming change. Effective 180 days after becoming law.

Statutes affected:
Introduced: 225 ILCS 65/50
Engrossed: 225 ILCS 65/50